These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7327451)

  • 1. [Comparative responsiveness of isolated saphenous, femoral and external carotid arteries and veins of dogs to dihydroergotamine mesylate (DEM) (author's transl)].
    Fukawa K; Honda H; Kubota H; Hatanaka Y; Sawabe T
    Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):223-30. PubMed ID: 7327451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of dihydroergotamine mesylate (DEM) on the cardiovascular and nervous systems (author's transl)].
    Fukawa K; Honda H; Kubota H; Hatanaka Y; Sawabe T
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):225-36. PubMed ID: 7084820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.
    Glusa E; Markwardt F
    Pharmacology; 1984; 29(6):336-42. PubMed ID: 6505006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies on the duration of action of dihydroergotamine.
    Müller-Schweinitzer E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):88-91. PubMed ID: 7372380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins.
    Glusa E; Müller-Schweinitzer E
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):133-6. PubMed ID: 8474533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of co-dergocrine mesylate and its components at vascular smooth muscle.
    Müller-Schweinitzer E
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):225-33. PubMed ID: 7063048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effect of dihydroergotamine and dihydroergotoxin in isolated human femoral veins and arteries.
    Glusa E; Markwardt F
    Pharmacology; 1982; 24(5):287-93. PubMed ID: 6285391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental pharmacological studies of the venous tonus-modifying effect of dihydroergotamine].
    Glusa E
    Z Gesamte Inn Med; 1984 Sep; 39(17):414-7. PubMed ID: 6095548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the pharmacology of venous smooth muscle from dog and man.
    Müller-Schweinitzer E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):690-704. PubMed ID: 94863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo studies after oral treatment of the beagle with dihydroergotamine.
    Müller-Schweinitzer E; Rosenthaler J
    Eur J Pharmacol; 1983 Apr; 89(1-2):1-8. PubMed ID: 6861880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.
    Müller-Schweinitzer E
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):113-8. PubMed ID: 940593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of S-dobutamine on venous blood return and organ nutrient blood flow.
    Pollock GD; Bowling N; Tuttle RR; Hayes JS
    J Cardiovasc Pharmacol; 1992; 20(5):742-9. PubMed ID: 1280736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasoconstrictor effects on isolated vessel segments determined by pressure-volume measurements].
    Weiss A; Koth W; Beer M; Glusa E; Markwardt F
    Biomed Biochim Acta; 1986; 45(10):1285-93. PubMed ID: 3566719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reversibility of canine vein-graft arterialization.
    Fann JI; Sokoloff MH; Sarris GE; Yun KL; Kosek JC; Miller DC
    Circulation; 1990 Nov; 82(5 Suppl):IV9-18. PubMed ID: 2225440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins.
    Flavahan NA; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Jul; 238(1):131-8. PubMed ID: 3014111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein.
    Cracowski JL; Stanke-Labesque F; Sessa C; Hunt M; Chavanon O; Devillier P; Bessard G
    Can J Physiol Pharmacol; 1999 Oct; 77(10):770-6. PubMed ID: 10588481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional differences of effects of ethanol on canine blood vessels.
    Yang HY; Liao JF; Shum AY; Chen CF
    Artery; 1987; 14(3):154-64. PubMed ID: 3593000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Techniques and complications of intravenous and intraarterial catheterization in dogs and cats.
    Burrows CF
    J Am Vet Med Assoc; 1973 Dec; 163(12):1357-63. PubMed ID: 4760081
    [No Abstract]   [Full Text] [Related]  

  • 19. Responses of human gastroepiploic arteries to vasoactive substances: comparison with responses of internal mammary arteries and saphenous veins.
    Ochiai M; Ohno M; Taguchi J; Hara K; Suma H; Isshiki T; Yamaguchi T; Kurokawa K
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):453-8. PubMed ID: 1495310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcium channel blockers on the contractile response to dihydroergotamine in isolated human femoral veins.
    Glusa E; Markwardt F
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):529-33. PubMed ID: 3614388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.